PMDA drug package insert
ミオテクター冠血管注
PMDA Prescription drug · 扶桑薬品工業株式会社 · package insert Oct 1, 2026
Key facts
| Brand names | ミオテクター冠血管注 |
|---|---|
| Nonproprietary names | 塩化ナトリウム・塩化カリウム配合剤 |
| Companies | 製造販売元／扶桑薬品工業株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 心臓外科手術用心停止及び心筋保護液 |
| Therapeutic category codes | 87799 |
| YJ codes | 7990500A1036 |
| Approval numbers | 22000AMX00184 |
| Package insert edition | 第2版 |
| Package insert date | Oct 1, 2026 |
| PMDA document key | 670156_7990500A1036_2 |
| PMDA company code | 670156 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: